Peter Wiklund

9PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyCellular nervous systemMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 17, 2026
Preoperative Circulating Tumor DNA Predicts Upstaging and Recurrence in High-Risk Nonmuscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.

Reuben Ben-David, Brendan L Raizenne, Ahmed Eraky

|Jun 16, 2025
Bladder neck involvement in non-muscle-invasive bladder cancer: risk implications and outcomes of BCG vs gemcitabine/docetaxel.

Ahmed Eraky, Reuben Ben-David, Brenda Hug

|Jan 23, 2025
Immunotherapy-based neoadjuvant treatment and complication rates after radical cystectomy.

Reuben Ben-David, Francesco Pellegrino, Reza Mehrazin

|Oct 16, 2024
Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomes.

Reuben Ben-David, Sarah Lidagoster, Jack Geduldig

|Jun 07, 2024
Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment.

Michelle A Tran, Dina Youssef, Sanjana Shroff

|May 08, 2024
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists.

Lars Björnebo, Shirin Razdan, Andrea Discacciati

Pageof 2

Frequent Collaborators

5 joint publications

Reuben Ben-David

5 joint publications

John P Sfakianos

5 joint publications

Reza Mehrazin

4 joint publications

Ahmed Eraky